NSE / BSEMaterials
β‚Ή106.90+0.45+0.42%
P/E0.0Mkt Capβ‚Ή2.90 K CrEV/EBITDA62.2

Camlin Fine Sciences Ltd

P/E0.0Mkt Capβ‚Ή2.90 K CrEV/EBITDA62.2
Company Profile

Camlin Fine Sciences Limited, together with its subsidiaries, research, develops, manufactures, and markets specialty chemicals, ingredients, and additive blend products in India and internationally. The company offers shelf-life solutions, which include basic ingredients, such as tert-butylhydroquinone (TBHQ), Butylated Hydroxyanisole (BHA), Butylated Hydroxytoluene (BHT), and Ascorbyl Palmitate (ASP); aroma ingredients, including vanillin and ethyl vanillin, natural vanillin, and some of its combinations; performance chemicals that include Hydroquinone (HQ), Catechol (CAT), Monomethyl Ether of HQ (MEHQ), tert butylcatechol (TBC), Guaiacol, and Veratrole; and health and wellness products comprising algae based products, such as Omega 3 fatty acids. It sells its prodycrts under the Xtendra, Nasure, Ezential, adorr, Dinamic, and Biosus brands. The company's products are used in food and beverage, pet food and rendering, animal nutrition, petrochemical, nutrition and health, biofuel, agrochemical, pharmaceutical, polymers, fragrance and flavor, and dyes and pigments industries. The company was formerly known as Camlin Fine Chemicals Ltd. and changed its name to Camlin Fine Sciences Limited in August 2011. Camlin Fine Sciences Limited was founded in 1931 and is headquartered in Mumbai, India.

Valuation

Market Cap
β‚Ή0.00
β€”
Current Price
β‚Ή0
β€”as of 26 Aug 2026
P/E Ratio
β€”
β€”
P/B Ratio
0.0x
β€”
EV / EBITDA
0.0x
β€”
EV / Sales
0.0x
β€”
52W High
β‚Ή0
β€”
52W Low
β‚Ή0
β€”
Shares Out
0.00 Cr
β€”

Profitability

Operating Margin
0.0%
β€”
Net Profit Margin
0.0%
β€”
EBITDA Margin
0.0%
β€”

Returns

ROE
0.0%
β€”
ROCE
0.0%
β€”
ROIC %
β€”
β€”
ROA
0.0%
β€”
Dividend Payout
0.0%
β€”

Solvency

Current Ratio
0.0x
β€”
Debt / Equity
0.0x
β€”
Debt / Assets
0.0x
β€”
CFO / Net Profit
0.0x
β€”
Interest Coverage
0.0x
β€”

AI Summary

Indian Stock

Sign up free to view AI insights

Get Started

Rule-based from financial data. Not advice.

Price Historyβ–Ό 51.20% over 1Y
Monthly Returns

Historically, Apr has averaged the highest return (+13.8%); Mar the lowest (-8.2%).

Average from:
YearJanFebMarAprMayJunJulAugSepOctNovDec
2026-2.0%Negative MonthJan 2026: -2.02%+2.2%Positive MonthFeb 2026: +2.17%-34.7%Negative MonthMar 2026: -34.71%+31.0%Positive MonthApr 2026: +30.96%-3.8%Negative MonthMay 2026: -3.76%+9.0%Positive MonthJun 2026: +9.00%-4.1%Negative MonthJul 2026: -4.13%-16.3%*Negative MonthAug 2026: -16.29%β€”β€”β€”β€”
2025-1.3%Neutral MonthJan 2025: -1.27%+13.0%Positive MonthFeb 2025: +12.96%+17.5%Positive MonthMar 2025: +17.45%-3.3%Negative MonthApr 2025: -3.31%+43.1%Positive MonthMay 2025: +43.12%+35.0%Positive MonthJun 2025: +35.01%-14.7%Negative MonthJul 2025: -14.68%-24.5%Negative MonthAug 2025: -24.53%-3.4%Negative MonthSep 2025: -3.37%+0.3%Neutral MonthOct 2025: +0.26%-15.7%Negative MonthNov 2025: -15.74%-10.0%Negative MonthDec 2025: -10.04%
2024-4.9%Negative MonthJan 2024: -4.86%-10.6%Negative MonthFeb 2024: -10.64%-22.7%Negative MonthMar 2024: -22.73%+19.0%Positive MonthApr 2024: +19.00%-11.6%Negative MonthMay 2024: -11.64%+10.0%Positive MonthJun 2024: +9.98%+17.3%Positive MonthJul 2024: +17.27%-15.0%Negative MonthAug 2024: -14.95%+0.0%Neutral MonthSep 2024: +0.00%+1.7%Neutral MonthOct 2024: +1.70%+17.0%Positive MonthNov 2024: +17.05%+4.6%Positive MonthDec 2024: +4.59%
2023-2.1%Negative MonthJan 2023: -2.09%-11.2%Negative MonthFeb 2023: -11.17%-8.5%Negative MonthMar 2023: -8.51%+35.3%Positive MonthApr 2023: +35.34%-2.3%Negative MonthMay 2023: -2.35%-3.4%Negative MonthJun 2023: -3.36%-3.8%Negative MonthJul 2023: -3.84%+5.8%Positive MonthAug 2023: +5.75%-1.0%Neutral MonthSep 2023: -1.00%-12.1%Negative MonthOct 2023: -12.12%-5.8%Negative MonthNov 2023: -5.80%+0.2%Neutral MonthDec 2023: +0.22%
2022+16.7%Positive MonthJan 2022: +16.67%-14.5%Negative MonthFeb 2022: -14.52%+7.4%Positive MonthMar 2022: +7.43%-12.8%Negative MonthApr 2022: -12.76%-3.3%Negative MonthMay 2022: -3.29%-8.3%Negative MonthJun 2022: -8.28%+9.3%Positive MonthJul 2022: +9.26%+10.9%Positive MonthAug 2022: +10.94%-9.8%Negative MonthSep 2022: -9.82%+33.3%Positive MonthOct 2022: +33.35%+2.2%Positive MonthNov 2022: +2.16%-0.4%Neutral MonthDec 2022: -0.44%
2021β€”β€”β€”β€”β€”+4.0%Positive MonthJun 2021: +3.95%+0.7%Neutral MonthJul 2021: +0.72%-8.0%Negative MonthAug 2021: -7.95%+5.8%Positive MonthSep 2021: +5.81%-9.6%Negative MonthOct 2021: -9.61%-16.1%Negative MonthNov 2021: -16.10%-6.3%Negative MonthDec 2021: -6.26%
AvgΒ±SD+1.3%Β±7.8%-4.2%Β±10.3%-8.2%Β±19.1%+13.8%Β±18.9%+4.4%Β±19.6%+7.7%Β±13.8%+0.8%Β±10.2%-7.8%Β±12.5%-1.7%Β±5.1%+2.7%Β±16.2%-3.7%Β±12.4%-2.4%Β±5.2%
* Current month β€” value will change until month-end.

Each cell is the percentage change in closing price from the end of the prior month to the end of this month. The bottom row shows the average return for that calendar month across the selected years, plus or minus one standard deviation β€” the range that historically contained roughly two-thirds of outcomes. Past monthly patterns are not a forecast of future returns.

Seasonal Tendency

This aggregates every month by calendar position β€” all Januaries together, all Februaries together, and so on β€” to show whether a given month has leaned positive or negative historically. β€˜Simple’ counts each month as +1 or βˆ’1. β€˜Weighted’ gives larger moves more influence: +2 above +10%, βˆ’2 below βˆ’10%. With only 6 years of history for this asset, each month’s score reflects a small number of observations β€” read it as a historical tendency, not a reliable seasonal pattern.

Historical Trend

This tracks a running tally across the asset’s full price history: each month adds or subtracts based on whether it was positive or negative. A rising line means more positive months than negative so far; a flattening or falling line means recent months have leaned negative. This measures historical month-to-month consistency, not expected future performance.

Year-to-Date ROI
Average from:
SD Γ—
Latest: 0.721x (2026)

Year-to-date return is calculated by dividing each day’s closing price by the price on January 1st of that year (or the asset’s first available price if it began trading mid-year). The custom average line shows the mean YTD return at each calendar day across the selected years. The standard deviation band shows the range within which returns have historically fallen β€” at 1 SD, roughly two-thirds of years; at 2 SD, roughly 95%. Past year-to-date patterns do not predict future returns. The average and standard deviation band are computed from the year set chosen in β€œAverage from”, which is independent of which year lines are displayed. The current in-progress year is excluded from these calculations, since a partial year is not comparable to complete ones. Election-cycle groupings follow the US presidential calendar and are offered only for US and crypto assets.

Historical Performance

Revenue, profitability, and cash flow trends (β‚Ή Crores)

Revenue (10Y)

Operating Income (10Y)

Net Profit (10Y)

Operating Margin % (10Y)

Dividend Payout % (10Y)

Free Cash Flow (10Y)

Growth Summary

Latest fiscal year: Mar 2025

Revenueβ‚Ή886.00 Crβ–² 14.6%
EBITDA Growthβ€”
Net Profitβ‚Ή-76.00β–² 49.0%
Cash from Ops (CFO)β€”
Free Cash Flow (FCF)β€”β–Ό 975.0%
Revenue CAGR 5Y5.9%
EBITDA CAGR 5Y-9.1%
Net Profit CAGR 5Y0.0%
NP Growth 1Y49.0%

Historical Growth

Year-by-year revenue, profitability, and cash flow (β‚Ή Crores, last 10 years)

YearRevenueOp. IncomeNet ProfitCFOFCFROERev Growth 1YNP Growth 1Y
Mar 2025β‚Ή886.00 Crβ€”β‚Ή-76.00β€”β€”-8.8%14.6%49.0%
Mar 2024β‚Ή773.00 Crβ€”β‚Ή-51.00β€”β€”-7.1%-2.0%-206.3%
Mar 2023β‚Ή789.00 Crβ€”β‚Ή48.00 Crβ€”β€”7.5%15.0%84.6%
Mar 2022β‚Ή686.00 Crβ€”β‚Ή26.00 Crβ€”β€”4.4%14.3%225.0%
Mar 2021β‚Ή600.00 Crβ€”β‚Ή8.00 Crβ€”β€”1.7%3.4%-74.2%
Mar 2020β‚Ή580.00 Crβ€”β‚Ή31.00 Crβ€”β€”8.2%5.8%181.8%
Mar 2019β‚Ή548.00 Crβ€”β‚Ή11.00 Crβ€”β€”3.2%36.0%-178.6%
Mar 2018β‚Ή403.00 Crβ€”β‚Ή-14.00β€”β€”-4.2%24.0%1300.0%
Mar 2017β‚Ή325.00 Crβ€”β‚Ή-1.00β€”β€”-0.6%-21.1%-103.8%
Mar 2016β‚Ή412.00 Crβ€”β‚Ή26.00 Crβ€”β€”21.5%-4.4%0.0%

Financial Statements

Income statement, balance sheet, and cash flow (β‚Ή Crores, as reported)

Consolidated Figures in USD Millions.

Unnamed: 0Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue / Net Sales374431412325403548580600686789773886913
Total Expenses315370344300395515517534605656738807841
EBIT / Operating Profit60616824833636680133358073
OPM %16%14%16%8%2%6%11%11%12%17%5%9%8%
Other Income12-113914215192917-7530
Finance Costs22212226262331363662627565
Depreciation & Amortisation91010129911192733495353
Profit Before Tax2932350-181441153667-60-123-15
Tax %35%19%26%809%-22%24%26%45%28%29%-14%-38%-
Net Profit / PAT192626-1-14113182648-51-76-4
EPS (β‚Ή)1.792.402.37-0.07-1.040.792.260.581.472.70-2.73-4.06-0.23
Dividend Payout %17%17%17%0%0%0%0%0%0%0%0%0%-

Peer Comparison

Materials sector peers, ranked by market cap

CompanyMarket CapRevenueP/EP/BEV/EBITDARev G 1Y
Camlin Fine Sciences Ltdthis co.β‚Ή2.90 K Crβ‚Ή886.00 Cr0.003.3662.2014.6%
UltraTech Cement Ltdβ‚Ή3.55 L Crβ‚Ή71.89 K Cr48.605.0227.234.7%
JSW Steel Limitedβ‚Ή2.88 L Crβ‚Ή1.28 L Cr38.003.4514.23-5.5%
Asian Paints Ltd.β‚Ή2.77 L Crβ‚Ή29.55 K Cr69.6014.5035.04-5.4%
Hindustan Zinc Ltd.β‚Ή2.66 L Crβ‚Ή33.97 K Cr25.5019.5718.5817.4%
Coal India Limitedβ‚Ή2.64 L Crβ‚Ή1.59 K Cr12.4013.2416.335.1%
Vedanta Limitedβ‚Ή2.49 L Crβ‚Ή74.30 K Cr26.503.3712.825.0%
Industry Averageβ€”β‚Ή10.75 K Cr47.545.2330.19121.8%

Learn while you research

Hand-picked academy chapters to deepen your understanding of Camlin Fine Sciences Ltd and the metrics that matter.

Browse the full Equiscale Academy